Last 67.50 INR
Change Today -0.40 / -0.59%
Volume 14.3K
CFIN On Other Exchanges
Symbol
Exchange
Mumbai
As of 4:20 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

camlin fine sciences ltd (CFIN) Snapshot

Open
67.20
Previous Close
67.90
Day High
69.00
Day Low
67.00
52 Week High
12/9/14 - 79.95
52 Week Low
01/30/14 - 10.40
Market Cap
6.5B
Average Volume 10 Days
92.7K
EPS TTM
3.06
Shares Outstanding
95.8M
EX-Date
07/24/14
P/E TM
22.1x
Dividend
0.35
Dividend Yield
0.52%
Current Stock Chart for CAMLIN FINE SCIENCES LTD (CFIN)

Related News

No related news articles were found.

camlin fine sciences ltd (CFIN) Related Businessweek News

No Related Businessweek News Found

camlin fine sciences ltd (CFIN) Details

Camlin Fine Sciences Limited manufactures and exports bulk drugs, fine chemicals, and food grade products in India and internationally. The company offers food ingredients, which primarily includes antox tert-butyl hydroquinone; antox butylated hydroxyanisole; and ascorbyl palmitate. It also provides industrial products consisting of guaiacol, an intermediate for manufacturing Vanillin; veratrole, an intermediate for the pharmaceutical and agrochemical industry; and tertiary butyl catechol, as well as hydroquinone mono methyl ether, which are polymerization inhibitors for use in the petrochemical industry. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was incorporated in 1993 and is based in Mumbai, India.

177 Employees
Last Reported Date: 05/25/11
Founded in 1993

camlin fine sciences ltd (CFIN) Top Compensated Officers

Managing Director, Director, Member of Stakeh...
Total Annual Compensation: 7.5M
Chief Financial Officer and Executive Directo...
Total Annual Compensation: 1.6M
Compensation as of Fiscal Year 2014.

camlin fine sciences ltd (CFIN) Key Developments

Camlin Fine Sciences Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Camlin Fine Sciences Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net profit for the period of INR 50.892 million or INR 0.53 per diluted share compared to net profit for the period of INR 58.123 million or INR 0.62 per diluted share a year ago. Net sales were INR 968.741 million compared to INR 945.817 million a year ago. Profit from operations before other income, interest & exceptional items was INR 115.689 million compared to INR 118.996 million a year ago. Profit from ordinary activities before tax was INR 71.204 million compared to INR 76.092 million a year ago. For the six months, the company reported net profit for the period of INR 105.585 million or INR 1.10 per diluted share compared to net profit for the period of INR 107.707 million or INR 1.15 per diluted share a year ago. Net sales were INR 1,851.741 million compared to INR 1,724.398 million a year ago. Profit from operations before other income, interest & exceptional items was INR 233.375 million compared to INR 230.750 million a year ago. Profit from ordinary activities before tax was INR 146.514 million compared to INR 146.180 million a year ago.

Camlin Fine Sciences Ltd., Board Meeting, Nov 13, 2014

Camlin Fine Sciences Ltd., Board Meeting, Nov 13, 2014. Agenda: To consider unaudited standalone earnings results for the second quarter and half year ended September 30, 2014.

Camlin Fine Sciences Ltd., Board Meeting, Jun 17, 2014

Camlin Fine Sciences Ltd., Board Meeting, Jun 17, 2014., at 11:30 Indian Standard Time. Agenda: To approve the sub division of equity shares of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CFIN:IN 67.50 INR -0.40

CFIN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CFIN.
View Industry Companies
 

Industry Analysis

CFIN

Industry Average

Valuation CFIN Industry Range
Price/Earnings 15.5x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 11.1x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAMLIN FINE SCIENCES LTD, please visit www.camlinfs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.